Y M Goh1, C Gillespie2, G Couper2, S Paterson-Brown2. 1. Department of General and Upper Gastro-Intestinal Surgery, The Royal Infirmary Of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, United Kingdom. Electronic address: yanmei.goh@doctors.org.uk. 2. Department of General and Upper Gastro-Intestinal Surgery, The Royal Infirmary Of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, United Kingdom.
Abstract
BACKGROUND: There remains debate as to whether quality of life (QoL) is better for patients following sub-total gastrectomy (SG) or total gastrectomy (TG) for cancer. Both have similar survival rates provided an R0 resection is performed and in many series the morbidity and mortality after TG is higher than SG. The aim of this study was to evaluate the QoL in patients after TG and SG for cancer. METHOD: All surviving patients who had undergone TG or SG between 1994 and 2009 were identified from a prospectively collected database and sent the European Organisation for Research and Treatment of Cancer (EORTC) core questionnaire (QLQ-C30 v.3) and the gastric module (QLQ-STO22). RESULTS: From a total of 261 patients who had undergone TG or SG in the study period, 91 were still alive and 53 responded. There was no significant difference between the QoL between TG and SG based on functional scales and global health status. However dysphagia and eating restrictions were significantly worse in the TG group. CONCLUSION: This study has demonstrated that there is no difference in overall QoL in patients with TG or SG although eating restrictions and dysphagia are worse after TG.
BACKGROUND: There remains debate as to whether quality of life (QoL) is better for patients following sub-total gastrectomy (SG) or total gastrectomy (TG) for cancer. Both have similar survival rates provided an R0 resection is performed and in many series the morbidity and mortality after TG is higher than SG. The aim of this study was to evaluate the QoL in patients after TG and SG for cancer. METHOD: All surviving patients who had undergone TG or SG between 1994 and 2009 were identified from a prospectively collected database and sent the European Organisation for Research and Treatment of Cancer (EORTC) core questionnaire (QLQ-C30 v.3) and the gastric module (QLQ-STO22). RESULTS: From a total of 261 patients who had undergone TG or SG in the study period, 91 were still alive and 53 responded. There was no significant difference between the QoL between TG and SG based on functional scales and global health status. However dysphagia and eating restrictions were significantly worse in the TG group. CONCLUSION: This study has demonstrated that there is no difference in overall QoL in patients with TG or SG although eating restrictions and dysphagia are worse after TG.
Authors: Won Jai Jung; Young Mok Park; Joo Han Song; Kyung Soo Chung; Song Yee Kim; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Sung Hoon Noh; Ji Yeong An; Young Ae Kang Journal: World J Gastroenterol Date: 2016-02-28 Impact factor: 5.742
Authors: Oh Kyoung Kwon; Byunghyuk Yu; Ki Bum Park; Ji Yeon Park; Seung Soo Lee; Ho Young Chung Journal: J Gastric Cancer Date: 2020-05-04 Impact factor: 3.720
Authors: Marianna Maspero; Carlo Sposito; Antonio Benedetti; Matteo Virdis; Maria Di Bartolomeo; Massimo Milione; Vincenzo Mazzaferro Journal: Ann Surg Oncol Date: 2022-01-01 Impact factor: 5.344